obesity-congress-diabetes-congress-2018-posters

5 / 22

Page 51
Note:
O c t o b e r 1 5 - 1 6 , 2 0 1 8 | T o k y o , J a p a n
Obesity Congress 2018, Diabetes Congress 2018 & Vaccines Congress 2018 Biomedical Research | ISSN: 0976-1683| Volume 29
2nd WORLD OBESITY CONGRESS
2nd WORLD VACCINES AND IMMUNOLOGY CONGRESS
&
&
DIABETES AND ENDOCRINOLOGY
International Conference on
Joint Event on
OF EXCELLENCE
IN INTERNATIONAL
MEETINGS
YEARS
Simon Raymond, Biomed Res 2018, Volume 29 | DOI: 10.4066/biomedicalresearch-C5-014
SITE ATTACHMENT INHIBITION: NEW
GENERATION IMMUNIZATION
Simon Raymond
Melbourne University, Australia
New Generation Immunization Programs. The current author anticipates
site attachment inhibition therapeutics to include: (A) drug (medication)
based therapies in treatment of established infections; (B) new generation
immunization methods (as preventative treatment) utilizing stem cell based
treatment (including prenatal and earlier, spanning back to oogenesis and
spermatogenesis) termed stc based immunization in previous publications.
With regards to new generation immunization programs, schedules to be de-
veloped would likely benefit from taking into consideration of the following.
1. Common infections to include taking into account the epidemiologi-
cal characteristics of the given population. Also,
2. Additional vaccination that may be required for children being born
with conditions predisposing them to particular infective agents.
Hypothetical Examples: Should persons with hereditary immune dysfunction
disorders receive additional immunizations? Should persons with cystic fi-
brosis receive additional protection?
• For instance: Haemophilus influenza; P. aeruginosa?
• Further research directed toward additional immunization, given like-
ly hospital attendance, against Clostridium difficile .
Note: there is currently a trial for a vaccine that is not stc based immunization,
against Clostridium difficile. Clover Trial:
NCT03090191. Interestingly, an article by the current author with regards
to Clostridium Difficile: Raymond S (2017) Site Attachment Inhibition: Case
Analysis Res HIV AIDS J SF 1: 1. Other infective agents and considerations
for inclusion on schedules is a topic for further discussion. The medical pro-
fession may need to head toward the future. It may be worth considering
whether such procedures should become routine as with procedure including
amniocentesis.
Simon Raymond is a Consultant specializing in Medical
and Scientific Research and an Alumnus of Melbourne
University (Rank of Number 1 in Australia and Number
33 in the World). The above stated Researcher has act-
ed as a Reviewer for the respected Medical Journal of
Australia, has received invitations internationally to re-
view from prestigious medical journals including Jour-
nal of American Medical Association Network. He has
received award in recognition of his research by Royal
Australasian College of Surgeons (PSC, 2006) and invit-
ed to conferences internationally as an official Delegate
and Researcher, including that in USA and China. He has
worked as the Principle Researcher in the highest-pow-
ered form of medical trial—Randomized Controlled Trial
(RCT). The above stated Researcher is also a Member
of the Golden Key International Society for Honored and
outstanding Academics and has been cited as a Notable
Global Leader.
BIOGRAPHY